Am J Drug Alcohol Abuse. 2008;34(4):449-61.

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.

Source

Penn State Harrisburg, Middletown, Pennsylvania 17057, USA.

Abstract

Random controlled trials on the efficacy of naltrexone and acamprosate in the treatment of alcohol dependence were reviewed, using a Relative Benefit (RB) analysis approach. A total of 42 studies were included, showing acamprosate use demonstrated a modest improvement, with a RB of 1.76 at three month follow-up. Short-term administration of naltrexone significantly reduced the relapse rate, but was not associated with modification in the abstinence rate. There was insufficient data available to ascertain the efficacy of naltrexone and acamprosate over prolonged periods of time, or the effectiveness of the medications relative to each other.

PMID:: 18584575; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Review Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. [Addiction. 2004]
Review Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.
Bouza C, Angeles M, Muñoz A, Amate JM. Addiction. 2004 Jul; 99(7):811-28.
Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. [Alcohol Alcohol. 2001]
Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
Rubio G, Jiménez-Arriero MA, Ponce G, Palomo T. Alcohol Alcohol. 2001 Sep-Oct; 36(5):419-25.
Pharmacological treatment of alcohol dependence: a review of the evidence. [JAMA. 1999]
Pharmacological treatment of alcohol dependence: a review of the evidence.
Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. JAMA. 1999 Apr 14; 281(14):1318-25.
Review Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment. [Eur Neuropsychopharmacol. 2003]
Review Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment.
Mason BJ. Eur Neuropsychopharmacol. 2003 Dec; 13(6):469-75.
Review Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective. [Am J Addict. 2003]
Review Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspective.
Soyka M, Chick J. Am J Addict. 2003; 12 Suppl 1:S69-80.

See reviews... See all...

Cited by 2 PubMed Central articles

Review How confident should we be that smoking cessation treatments work? [Addiction. 2009]
Review How confident should we be that smoking cessation treatments work?
Hughes JR. Addiction. 2009 Oct; 104(10):1637-40. Epub 2009 Aug 4.
Review Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. [Theor Biol Med Model. 2008]
Review Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.
Blum K, Chen AL, Chen TJ, Braverman ER, Reinking J, Blum SH, Cassel K, Downs BW, Waite RL, Williams L, et al. Theor Biol Med Model. 2008 Nov 12; 5:24. Epub 2008 Nov 12.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependenc...
The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.
Am J Drug Alcohol Abuse. 2008 ;34(4):449-61.

PubMed
Ocular HSV-1 latency, reactivation and recurrent disease.
Ocular HSV-1 latency, reactivation and recurrent disease.
Semin Ophthalmol. 2008 Jul-Aug ;23(4):249-73.

PubMed
Impact of occult hepatitis B virus infection and prior hepatitis B virus infecti...
Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Scand J Gastroenterol. 2008 ;43(7):849-56.

PubMed
Derivation of clinical predictors of failed rescue shock during out-of-hospital ...
Derivation of clinical predictors of failed rescue shock during out-of-hospital ventricular fibrillation.
Prehosp Emerg Care. 2008 Jul-Sep ;12(3):347-51.

PubMed
Accuracy of stroke recognition by emergency medical dispatchers and paramedics--...
Accuracy of stroke recognition by emergency medical dispatchers and paramedics--San Diego experience.
Prehosp Emerg Care. 2008 Jul-Sep ;12(3):307-13.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trials.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information